148 related articles for article (PubMed ID: 25622345)
61. Superficial basal cell carcinoma successfully treated with ingenol mebutate gel 0.05%.
Cantisani C; Paolino G; Cantoresi F; Faina V; Richetta AG; Calvieri S
Dermatol Ther; 2014; 27(6):352-4. PubMed ID: 25052730
[No Abstract] [Full Text] [Related]
62. Topical chemotherapy of advanced cutaneous malignancy with 5-Fluorouracil creme.
Litwin MS; Ryan RF; Reed RJ; Krementz ET
J Surg Oncol; 1971; 3(3):351-65. PubMed ID: 5110339
[No Abstract] [Full Text] [Related]
63. High frequency 40-MHz ultrasound. A possible noninvasive method for the assessment of the boundary of basal cell carcinomas.
Gupta AK; Turnbull DH; Foster FS; Harasiewicz KA; Shum DT; Prussick R; Watteel GN; Hurst LN; Sauder DN
Dermatol Surg; 1996 Feb; 22(2):131-6. PubMed ID: 8608374
[TBL] [Abstract][Full Text] [Related]
64. Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma.
Glass LF; Jaroszeski M; Gilbert R; Reintgen DS; Heller R
J Am Acad Dermatol; 1997 Oct; 37(4):596-9. PubMed ID: 9344200
[TBL] [Abstract][Full Text] [Related]
65. Resident rounds part III: plaque on left areola of an African-American woman.
Goddard L; Mollet T; Blalock T
J Drugs Dermatol; 2014 Jun; 13(6):767. PubMed ID: 25061653
[TBL] [Abstract][Full Text] [Related]
66. 5-fluorouracil ointment in tumors of the skin.
De Moragas JM; Gimenez-Camarasa JM
Dermatologica; 1970; 140():Suppl 1:65-74. PubMed ID: 5471365
[No Abstract] [Full Text] [Related]
67. A follow-up study of treatment of basal cell carcinoma with 5-fluorouracil ointment.
Reymann F
Dermatologica; 1972; 144(4):205-8. PubMed ID: 5076720
[No Abstract] [Full Text] [Related]
68. Effect of topical tubercidin on basal cell carcinomas and actinic keratoses.
Burgess GH; Bloch A; Stoll H; Milgrom H; Helm F; Klein E
Cancer; 1974 Aug; 34(2):250-3. PubMed ID: 4851709
[No Abstract] [Full Text] [Related]
69. Local chemotherapy in cutaneous neoplasms.
Klein E
JAMA; 1972 Nov; 222(9):1167-8. PubMed ID: 4678056
[No Abstract] [Full Text] [Related]
70. Treatment of cutaneous neoplasms by intralesional injections of 5-fluorouracil (5-FU).
Kurtis B; Rosen T
J Dermatol Surg Oncol; 1980 Feb; 6(2):122-7. PubMed ID: 7354186
[TBL] [Abstract][Full Text] [Related]
71. Topical 5% 5-fluorouracil versus procedural modalities for squamous cell carcinoma in situ and superficial basal cell carcinoma: A retrospective cohort analysis.
Neale H; Michelon M; Jacob S; Pinkston M; Ukaegbu R; Zamor W; Morrison E; Deng A; Levin NA
J Am Acad Dermatol; 2022 Aug; 87(2):423-425. PubMed ID: 34478783
[No Abstract] [Full Text] [Related]
72. Topical 5-fluorouracil: variability of effective dosage and duration of reaction.
Sykes MP; Salem P; Joffe B
J Am Geriatr Soc; 1971 Dec; 19(12):977-82. PubMed ID: 5153692
[No Abstract] [Full Text] [Related]
73. Intralesional 5-Fluorouracil in the Treatment of Lower Leg Squamous Cell Carcinoma.
Mackey M; Shahsavari A; Mackey VT
J Drugs Dermatol; 2018 Nov; 17(11):1241-1243. PubMed ID: 30500149
[TBL] [Abstract][Full Text] [Related]
74. Topical chemotherapy of cutaneous malignancy of the head and neck.
Litwin MS; Ryan RF; Reed RJ; Krementz ET
South Med J; 1969 May; 62(5):556-8. PubMed ID: 5782184
[No Abstract] [Full Text] [Related]
75. The clinical application of 5-fluorouracil in the treatment of skin lesions. Comment.
Snyderman RK
Plast Reconstr Surg; 1973 Sep; 52(3):298. PubMed ID: 4723135
[No Abstract] [Full Text] [Related]
76. Basal cell nevus syndrome and adenocarcinoma of the colon. Response to systemic fluorouracil.
Stone SP
Int J Dermatol; 1979 Jun; 18(5):398-401. PubMed ID: 468461
[TBL] [Abstract][Full Text] [Related]
77. Summary of our trial with 5-fluorouracil (5-FU) ointment on the treatment of basal cell epithelioma and senile keratosis.
Scarpa C
Dermatologica; 1970; 140():Suppl 1:114-8. PubMed ID: 5471356
[No Abstract] [Full Text] [Related]
78. Therapeutic perspectives in actinic and other keratoses.
Schwartz RA
Int J Dermatol; 1996 Aug; 35(8):533-8. PubMed ID: 8854146
[No Abstract] [Full Text] [Related]
79. The effect of intralesional 5-fluorouracil therapeutic implant (MPI 5003) for treatment of basal cell carcinoma.
Orenberg EK; Miller BH; Greenway HT; Koperski JA; Lowe N; Rosen T; Brown DM; Inui M; Korey AG; Luck EE
J Am Acad Dermatol; 1992 Nov; 27(5 Pt 1):723-8. PubMed ID: 1430394
[TBL] [Abstract][Full Text] [Related]
80. Topical 5-fluorouracil to treat multiple or unresectable facial squamous cell carcinomas in xeroderma pigmentosum.
Hamouda B; Jamila Z; Najet R; Slim T; Rafiaa N; Noureddine B; Ahmed EM; Mohamed F; Ridha KM; Abderrahman L
J Am Acad Dermatol; 2001 Jun; 44(6):1054. PubMed ID: 11369927
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
